172 related articles for article (PubMed ID: 10945302)
1. Amplification of the cyclin A gene in canine and feline mammary tumors.
Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
J Vet Med Sci; 2000 Jul; 62(7):783-7. PubMed ID: 10945302
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.
Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
J Vet Med Sci; 2000 Jul; 62(7):743-50. PubMed ID: 10945293
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the c-yes oncogene in canine mammary tumors.
Rungsipipat A; Tateyama S; Yamaguchi R; Uchida K; Murakami Y; Miyoshi N; Hayashi T
J Vet Med Sci; 1999 Feb; 61(2):185-9. PubMed ID: 10081762
[TBL] [Abstract][Full Text] [Related]
4. Telomere length and telomerase activity in canine mammary gland tumors.
Yazawa M; Okuda M; Setoguchi A; Iwabuchi S; Nishimura R; Sasaki N; Masuda K; Ohno K; Tsujimoto H
Am J Vet Res; 2001 Oct; 62(10):1539-43. PubMed ID: 11592316
[TBL] [Abstract][Full Text] [Related]
5. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours.
Millanta F; Asproni P; Canale A; Citi S; Poli A
Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
7. Abnormal structure of the canine oncogene, related to the human c-yes-1 oncogene, in canine mammary tumor tissue.
Miyoshi N; Tateyama S; Ogawa K; Yamaguchi R; Kuroda H; Yasuda N; Shimizu T
Am J Vet Res; 1991 Dec; 52(12):2046-9. PubMed ID: 1789521
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in feline tumour suppressor gene p53. Mutations in an osteosarcoma and a mammary carcinoma.
Mayr B; Reifinger M; Loupal G
Vet J; 1998 Jan; 155(1):103-6. PubMed ID: 9455165
[No Abstract] [Full Text] [Related]
9. Novel canine tumour suppressor gene p53 mutations in cases of skin and mammary neoplasms.
Mayr B; Reifinger M; Alton K
Vet Res Commun; 1999 Aug; 23(5):285-91. PubMed ID: 10493115
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic variation in six cases of feline mammary tumours.
Mayr B; Jugl M; Brem G; Reifinger M; Loupal G
Zentralbl Veterinarmed A; 1999 Aug; 46(6):367-77. PubMed ID: 10481616
[TBL] [Abstract][Full Text] [Related]
11. Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor.
Kubo K; Matsuyama S; Katayama K; Tsutsumi C; Yonezawa K; Shimada T; Kotani T; Sakuma S; Ohashi F; Takamori Y
J Vet Med Sci; 1998 Dec; 60(12):1335-40. PubMed ID: 9879535
[TBL] [Abstract][Full Text] [Related]
12. Feline STK gene expression in mammary carcinomas.
De Maria R; Maggiora P; Biolatti B; Prat M; Comoglio PM; Castagnaro M; Di Renzo MF
Oncogene; 2002 Mar; 21(11):1785-90. PubMed ID: 11896610
[TBL] [Abstract][Full Text] [Related]
13. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
Lee CH; Kweon OK
J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
[TBL] [Abstract][Full Text] [Related]
14. PKM2 in Canine Mammary Tumors: Parallels to Human Breast Cancer.
Lee HJ; Han HJ; Lee JY; Son WC
Comp Med; 2020 Aug; 70(4):349-354. PubMed ID: 32718384
[TBL] [Abstract][Full Text] [Related]
15. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
16. Feline malignant mammary tumors. I. Morphology and biology: some comparisons with human and canine mammary carcinomas.
Weijer K; Head KW; Misdorp W; Hampe JF
J Natl Cancer Inst; 1972 Dec; 49(6):1697-704. PubMed ID: 4346020
[No Abstract] [Full Text] [Related]
17. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019.
Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N
PeerJ; 2024; 12():e17077. PubMed ID: 38500523
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression in canine mammary tumors.
Doré M; Lanthier I; Sirois J
Vet Pathol; 2003 Mar; 40(2):207-12. PubMed ID: 12637762
[TBL] [Abstract][Full Text] [Related]
19. Co-localization of PTEN and E-cadherin in canine mammary hyperplasias and benign and malignant mammary tumors.
Asproni P; Ressel L; Millanta F; Vannozzi I; Poli A
Res Vet Sci; 2015 Dec; 103():113-8. PubMed ID: 26679805
[TBL] [Abstract][Full Text] [Related]
20. Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study.
Martin de las Mulas J; Ordás J; Millán Y; Fernández-Soria V; Ramón y Cajal S
Breast Cancer Res Treat; 2003 Aug; 80(3):363-7. PubMed ID: 14503809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
